The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Idelalisib monotherapy and durable responses in patients with relapsed or refractory Waldenstroms Macroglobulinemia (WM).
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; Celgene; Gilead Sciences; Novartis; Pharmacyclics
 
John Leonard
Consulting or Advisory Role - Gilead Sciences
 
Christopher Flowers
Consulting or Advisory Role - Algeta ASA; OptumRx; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
Other Relationship - Celgene
 
Andrew John Davies
Honoraria - Gilead Sciences; Janssen Oncology; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Mundipharma; Pfizer; Roche; Takeda
Research Funding - Bayer (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche; Takeda
 
Wojciech Jurczak
Consulting or Advisory Role - Mundipharma; Novartis; Spectrum Pharmaceuticals; Takeda; Teva
Research Funding - Celgene; Eisai; Gilead Sciences; Janssen; Novartis; Pfizer; Pharmacyclics; Roche Pharma AG; Spectrum Pharmaceuticals; Takeda; Teva
 
John C. Byrd
No Relationships to Disclose
 
Stephen Edward Forbes Spurgeon
Consulting or Advisory Role - Genentech; Gilead Sciences; Pharmacyclics
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Gilead Sciences; Janssen
 
Sissy Peterman
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Leanne Holes
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Yoonjin Cho
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Bess Sorenson
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Wayne Russell Godfrey
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Ajay K. Gopal
Honoraria - Seagen; Takeda
Consulting or Advisory Role - Gilead Sciences; Janssen; Pfizer; Seagen
Speakers' Bureau - Seagen; Takeda
Research Funding - Abbott Laboratories; Biogen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen; Merck Sharp & Dohme; Pfizer; Seagen; Spectrum Pharmaceuticals; Takeda